

BPC-157 + TB-500 Blend + GHK-Cu Set
BPC-157 + TB-500 Blend 10mg + GHK-Cu 50mg. A combined repair and dermal-matrix research set.


Bundle
DSIP 5mg + Epithalon 10mg. Sleep-architecture and cellular-senescence research pairing.
Select size
Quantity
Total
$94.00
That's the price. No inflated list, no permanent “discount” code to make it look cheaper than it is.
COA pending. The certificate for this lot will be uploaded to our COA library as soon as we have it.
Have a question?
For research use only. Not for human consumption.
Products supplied by Synthrex Biotech LLC are intended strictly for in-vitro laboratory research and development by qualified professionals. They are not drugs, foods, cosmetics, or dietary supplements, and are not approved by the FDA for human or veterinary use. They are not sold for, and must not be used for, human or animal consumption or administration of any kind. Synthrex Biotech LLC is not a compounding pharmacy or chemical compounding facility as defined under section 503A of the Federal Food, Drug, and Cosmetic Act, and is not an outsourcing facility as defined under section 503B of that Act. By purchasing, you affirm that you are a qualified researcher acquiring these materials for lawful research purposes only. A Safety Data Sheet (SDS/MSDS) is available on request for every compound.
Sold by Synthrex Biotech LLC. A Safety Data Sheet (SDS) is available on request at support@synthrexbiotech.com.
Every vial carries its own batch number, exactly as it would if bought separately. Every certificate is published and available for review. No published literature characterises this combination as a single entity.
A delta sleep-inducing peptide studied in sleep-architecture and neuroendocrine research.
COA pending. The certificate for this lot will be uploaded to our COA library as soon as we have it.
Full research notes and sources for DSIP →A synthetic tetrapeptide studied in telomere-biology and cellular-senescence research.
Certificate of Analysis: SYX-EPI50-0726
Full research notes and sources for Epithalon →Delta sleep-inducing peptide is a nonapeptide isolated in 1977 by Guido Schoenenberger and Marcel Monnier in Switzerland, from the cerebral venous blood of rabbits in an induced sleep state. The isolation method is the memorable part: they transfused blood from sleeping animals into recipients and looked for a transferable factor. The peptide has proven durably mysterious — a 2006 review in the Journal of Neurochemistry is titled, accurately, “a still unresolved riddle.”
Despite nearly fifty years of study, no receptor for DSIP has been identified, and its endogenous function is not established. Published work describes effects observed in various animal models, but without a characterised receptor or a reproducible mechanism the literature remains inconclusive — which is what the “unresolved riddle” framing refers to. We would rather tell you that than manufacture a mechanism. Not FDA-approved for any use.
Epithalon (also written epitalon) is a synthetic tetrapeptide, Ala-Glu-Asp-Gly, developed by Vladimir Khavinson at the St Petersburg Institute of Bioregulation and Gerontology. It is the synthetic counterpart of epithalamin, a polypeptide extract of the pineal gland that Khavinson’s group worked on from the 1970s. It belongs to the broader Russian “peptide bioregulator” programme — short peptides proposed to act at the level of gene expression, a research tradition largely conducted within Russian institutions and, for most of its history, published in Russian-language journals.
The published mechanism claim is that short peptides of this type interact with DNA and influence gene expression, with the specific proposal that epithalon affects telomerase expression in cell culture. A 2025 review in the International Journal of Molecular Sciences provides the most accessible English-language overview of the compound and its reported properties. Read that literature knowing its provenance: much of the primary work originates from a single research group, and independent replication outside that programme is limited. Not FDA-approved for any use.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Summaries of published literature for research reference only. Not a claim about any product’s effect.
Batch releases & restocks
Every certificate is published and available for review. Join the Lab List and we'll tell you when a new one lands and when a sold-out compound is back — plus 15% off your first order, shown on screen the second you join.
Batch and restock notices from Synthrex Biotech LLC. No dosing advice, ever. One-click unsubscribe on every email.


BPC-157 + TB-500 Blend 10mg + GHK-Cu 50mg. A combined repair and dermal-matrix research set.


GLOW Blend 70mg + GHK-Cu 50mg. Copper-peptide focused preparation set for dermal research models.


KLOW Blend 80mg + KPV 10mg. A four-compound blend paired with an alpha-MSH fragment for multi-pathway research.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.